SAN FRANCISCO, CA, UNITED STATES, October 27, 2025 /EINPresswire.com/ — Solaris Endovascular, Inc., a U.S.-based, growth-stage medical device company pioneering next-generation endovascular stent-graft technology, today shared interim results from the DEScover Clinical Trial at the Transcatheter Cardiovascular Therapeutics (TCT) 2025 conference. The data mark a major advance in the treatment […]